QMA

CVS Health Corp. (CVS) — QMA analysis

Sector: Healthcare · Market cap: $97.5B · Price: $93.47 · Data as of 2026-10-24

65
/100
A
Composite grade
Higher score than 97% of 22,734 tracked stocks

CVS Health Corp. has an above-average composite score of 65/100, higher score than 97% of 22,734 tracked stocks. The highest-scoring layer is Catalysts; the lowest is Insider activity.

Analytical score, not investment advice. No score is an instruction or a guarantee. Past performance ≠ future results.
Share this analysis
𝕏in

What 13 data layers say about CVS

The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.

LayerScore
Fundamental value (FVS)75/100
Earnings quality (EQS)83/100
Technical trend (TSS)44/100
Relative strength (RS)41/100
Momentum (USS)40/100
Insider activity (IAS)18/100
Off-exchange trading (FINRA) / large flows (WHS)55/100
Institutional 13F (IFS)61/100
Options flow (OFS)72/100
Congressional trades (PTS)38/100
News sentiment (NSS)57/100
Analysts / transcripts (ATS)76/100
Catalysts (XS)95/100

What does the QMA model currently show for CVS Health Corp.?

The composite score is an entry point, not a signal. What matters is layer confluence — whether they point the same direction.

For CVS the layers diverge — some score high (Catalysts), others low (Insider activity). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.

CVS insider & smart money activity

Over the recent period we record 6 reported insider purchases and 13 sales for CVS: predominance of reported sales (by dollar value). A description of the data layer, not an instruction.

CVS seasonality

The historically strong window for CVS comes up December 1–28 with a hit rate of 70% and an average move of 1.7% (21 years of history).

Historical data does not guarantee future results.

CVS dividend

CVS Health Corp. currently carries a dividend yield of 2.85% and has paid for 42 years in a row (dividend aristocrat).

How CVS compares

Similar stocks from the same sector:

Frequently asked questions

What is the composite score for CVS stock?

65/100 (grade A) as of 2026-10-24, fusing 13 data layers. An analytical score, not advice.

Are insiders buying CVS stock?

Over the recent period, reported: purchases 6, sales 13 (purchases $924K, sales $343M). Insider activity: predominance of reported sales (by dollar value) — a description of reported data, not a trade instruction.

Where can I see live CVS data?

Live CVS data and the full screener are part of full access. Registration is free with no card — trial full access, then the free plan with a delayed data sample.

Explore more — for free

The CVS score is just the start. Keep going free in the QMA magazine — analysis, tools and learning with no payment up front.

Free registration, no card — trial full access, then the free plan

Want the full CVS analysis with all layers and live data? Open CVS detail →

Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.

⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.

Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]